Helen Torley: CEO of Halozyme Therapeutics

Portrait of Helen Torley

Helen Torley, CEO of Halozyme Therapeutics, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Halozyme is working to reinvent the patient experience by easing the burden of treatment and improving patient outcomes.

Regeneron Annual Report Cover Detail
Regeneron

Annual Report

Acme United Annual Report detail
Acme United

Cutting Edge Technology

Gemini Therapeutics employee in lab.
Gemini Therapeutics

We See Disease Differently